ロード中...
Sirolimus Therapy to Halt the Progression of ADPKD
Activation of mammalian target of rapamycin (mTOR) pathways may contribute to uncontrolled cell proliferation and secondary cyst growth in patients with autosomal dominant polycystic kidney disease (ADPKD). To assess the effects of mTOR inhibition on disease progression, we performed a randomized, c...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Nephrology
2010
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2900967/ https://ncbi.nlm.nih.gov/pubmed/20466742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2009121302 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|